Doxapram hydrochloride hydrate (盐酸多沙普仑水合物) 能抑制TASK-1,TASK-3和TASK-1/TASK-3异二聚体通道,EC50分别为410 nM,37 μM和9 μM。
Doxapram HCl inhibits TASK-1, TASK-3, TASK-1/TASK-3 heterodimeric channel function with EC50 of 410 nM, 37 μM, 9 μM, respectively.
动物 A (mg/kg) = 动物 B (mg/kg)×动物 B的Km系数/动物 A的Km系数 | |
例如,已知某工具药用于小鼠的剂量为88 mg/kg , 则用于大鼠的剂量换算方法:将88 mg/kg 乘以小鼠的Km系数(3),再除以大鼠的Km系数(6),得到该药物用于大鼠的等效剂量44 mg/kg。
[1] Cotten JF, et al. Anesth Analg, 2006, 102(3), 779-785.
[2] Peers, C., Effects of doxapram on ionic currents recorded in isolated type I cells of the neonatal rat carotid body. Brain Res, 1991. 568(1-2): p. 116-22.
[3] Anderson-Beck, R., et al., Doxapram stimulates dopamine release from the intact rat carotid body in vitro. Neurosci Lett, 1995. 187(1): p. 25-8.
分子式 C24H33ClN2O3 |
分子量 432.98 |
CAS号 7081-53-0 |
储存方式 ﹣20 ℃冷藏长期储存。冰袋运输 |
溶剂(常温) |
DMSO 85 mg/mL |
Water 25 mg/mL |
Ethanol 2 mg/mL |
体内溶解度
NCT Number | Conditions | Interventions | Sponsor/Collaborators | Phases | Start Date | Last Updated |
NCT00389909 | Premature Infants|Apnea | Drug: Doxapram | Jean Michel Hascoet|Maternite Regionale Universitaire | Phase 4 | 2006-11-01 | 2017-02-23 |
NCT02171910 | Sedation|Hypoxia | Drug: Doxapram|Drug: Placebo | Helsinki University Central Hospital | Phase 4 | 2016-10-01 | 2016-12-02 |
NCT02820025 | Anesthesia | Drug: doxapram|Other: saline | General Hospital of Ningxia Medical University | 2015-10-01 | 2017-01-17 | |
NCT00477451 | Panic Attack | Drug: placebo|Drug: alprazolam | Alexza Pharmaceuticals, Inc. | Phase 2 | 2007-05-01 | 2017-01-30 |
NCT02421068 | Premature Birth | Sinno H.P. Simons|ZonMw: The Netherlands Organisation for Health Research and Development|Leiden Amsterdam Centre for Drug Research (LACDR)|Dutch Knowledge Centre for Pediatric Pharmacotherapy (NKFK)|Centre for Human Drug Research, Netherlands|Radboud University|Erasmus Medical Center | 2014-08-01 | 2017-02-08 | ||
NCT01344317 | Apneas of Prematurity | Medical University of Vienna | 2009-06-01 | 2015-10-30 |
注:以上所有数据均来自公开文献,并不保证对所有实验均有效,数据仅供参考。
相关化合物库
使用AMQUAR产品发表文献后请联系我们